American Heart Journal
Volume 160, Issue 2 , Pages 279-285 , August 2010

Serum albumin concentration and heart failure risk: The Health, Aging, and Body Composition Study

  • Deepa M. Gopal, MD, MS

      Affiliations

    • Boston University, Boston, MA
    • ,
  • Andreas P. Kalogeropoulos, MD

      Affiliations

    • Emory University, Atlanta, GA
    • ,
  • Vasiliki V. Georgiopoulou, MD

      Affiliations

    • Emory University, Atlanta, GA
    • ,
  • Wilson W.H. Tang, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Amanda Methvin, MD

      Affiliations

    • Emory University, Atlanta, GA
    • ,
  • Andrew L. Smith, MD

      Affiliations

    • Emory University, Atlanta, GA
    • ,
  • Douglas C. Bauer, MD

      Affiliations

    • University of California San Francisco, San Francisco, CA
    • ,
  • Anne B. Newman, MD, MPH

      Affiliations

    • University of Pittsburgh, Pittsburgh, PA
    • ,
  • Lauren Kim, MD

      Affiliations

    • Intramural Research Program, National Institute of Aging, National Institutes of Health, Bethesda, MD
    • ,
  • Tamara B. Harris, MD, MS

      Affiliations

    • Intramural Research Program, National Institute of Aging, National Institutes of Health, Bethesda, MD
    • ,
  • Stephen B. Kritchevsky, PhD

      Affiliations

    • Sticht Center on Aging, Wake Forest University, Winston Salem, NC
    • ,
  • Javed Butler, MD, MPH

      Affiliations

    • Emory University, Atlanta, GA
    • Corresponding Author InformationReprint requests: Javed Butler, MD, MPH, Emory University Hospital, 1365 Clifton Rd NE, Suite AT430, Atlanta, GA 30322.
    • ,
  • for the Health ABC Study

Received 11 March 2010 ,Accepted 14 May 2010.

References 

  1. Gillum RF, Makuc DM. Serum albumin, coronary heart disease, and death. Am Heart J. 1992;123:507–513
  2. Klonoff-Cohen H, Barrett-Connor EL, Edelstein SL. Albumin levels as a predictor of mortality in the healthy elderly. J Clin Epidemiol. 1992;45:207–212
  3. Kuller LH, Eichner JE, Orchard TJ, et al. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1991;134:1266–1277
  4. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989;2:1434–1436
  5. Schalk BW, Visser M, Bremmer MA, et al. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am J Epidemiol. 2006;164:969–977
  6. Horwich TB, Kalantar-Zadeh K, MacLellan RW, et al. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883–889
  7. Butler J, Kalogeropoulos A, Georgiopoulou V, et al. for the Health ABC Study. Incident heart failure prediction in the elderly: the Health ABC Heart Failure Score. Circ Heart Failure. 2008;1:125–133
  8. Baumgartner RN, Koehler KM, Romero L, et al. Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr. 1996;64:552–558
  9. Rao M, Guo D, Perianayagam MC, et al. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2005;45:324–333
  10. Yeun JY, Levine RA, Mantadilok V, et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35:469–476
  11. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432–437
  12. Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108:2317–2322
  13. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263–276
  14. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165:2460–2466
  15. Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512–5528
  16. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509
  17. Foley RN, Parfrey PS, Harnett JD, et al. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7:728–736
  18. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341–353
  19. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201–1206
  20. Tsutamoto T, Hisanaga T, Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:391–398
  21. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241
  22. Raymond RJ, Dehmer GJ, Theoharides TC, et al. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J. 2001;141:435–438
  23. Williams ES, Shah SJ, Ali S, et al. C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. Eur J Heart Fail. 2008;10:63–69
  24. El-Menyar AA. Cytokines and myocardial dysfunction: state of the art. J Card Fail. 2008;14:61–74
  25. Kuwahara F, Kai H, Tokuda K, et al. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?. Hypertension. 2004;43:739–745
  26. Bahrami H, Bluemke DA, Kronmal R, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51:1775–1783
  27. Westermann D, Van Linthout S, Dhayat S, et al. Tumor necrosis factor–alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol. 2007;102:500–507
  28. Van Linthout S, Riad A, Dhayat N, et al. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia. 2007;50:1977–1986

PII: S0002-8703(10)00428-X

doi: 10.1016/j.ahj.2010.05.022

American Heart Journal
Volume 160, Issue 2 , Pages 279-285 , August 2010

Article Tools

* Image Usage & Resolution